Sanofi’s Zika vaccine gets funding | Chemical & Engineering News
Volume 94 Issue 39 | p. 18 | Concentrates
Issue Date: October 3, 2016

Sanofi’s Zika vaccine gets funding

Department: Business
Keywords: global health, Zika, vaccines, pharmaceuticals

The U.S. Biomedical Advanced Research & Development Authority will give Sanofi $43.2 million to support the manufacturing of a Zika vaccine. In July, the Walter Reed Army Institute of Research transferred its technology for a purified, inactivated Zika virus (ZPIV) vaccine to Sanofi, which agreed to commercialize it. The cash from BARDA will allow Sanofi to improve yields and make the vaccine for Phase II trials. Walter Reed and NIH are conducting Phase I trials.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment